Mahajan Anish P, Kinsler Janni J, Cunningham William E, James Saloniki, Makam Lakshmi, Manchanda Rishi, Shapiro Martin F, Sayles Jennifer N
AIDS Behav. 2016 Jan;20(1):107-114. doi: 10.1007/s10461-015-1222-8.
HIV/AIDS-related stigma is a key factor impeding patient utilization of HIV testing services. To destigmatize HIV testing, the Centers for Disease Control and Prevention recommended an 'opt-out' screening strategy aimed at all patients in all clinical settings, regardless of HIV risk. This study assessed whether opt-out screening as compared to opt-in screening was associated with increased uptake of HIV testing among patients with HIV/AIDS-related stigma concerns. This study included 374 patients attending two Los Angeles ambulatory care clinics. Stigma items were grouped into three constructs: Blame/isolation, abandonment, and contagion. Individuals endorsing the blame/isolation subscale (AOR = 0.52; 95 % CI 0.29-0.92; p\0.05) and abandonment subscale (AOR = 0.27; 95 % CI 0.13-0.59; p\0.01) were significantly less likely to accept an HIV test. Additionally, the opt-out model did not counter the negative effects of stigma on HIV test acceptance. These findings indicate that stigma remains a barrier to HIV testing, regardless of the opt-out screening approach.
与艾滋病毒/艾滋病相关的污名化是阻碍患者利用艾滋病毒检测服务的一个关键因素。为了消除对艾滋病毒检测的污名化,美国疾病控制与预防中心建议采用一种“选择退出”的筛查策略,该策略适用于所有临床环境中的所有患者,无论其感染艾滋病毒的风险如何。本研究评估了与“选择加入”筛查相比,“选择退出”筛查是否与那些担心与艾滋病毒/艾滋病相关污名化的患者增加艾滋病毒检测接受度有关。本研究纳入了374名在洛杉矶两家门诊护理诊所就诊的患者。污名化项目被分为三个结构:责备/孤立、抛弃和传染。认可责备/孤立子量表(调整后比值比[AOR] = 0.52;95%置信区间[CI] 0.29 - 0.92;p < 0.05)和抛弃子量表(AOR = 0.27;95% CI 0.13 - 0.59;p < 0.01)的个体接受艾滋病毒检测的可能性显著降低。此外,“选择退出”模式并未抵消污名化对艾滋病毒检测接受度的负面影响。这些发现表明,无论采用“选择退出”筛查方法与否,污名化仍然是艾滋病毒检测的一个障碍。